{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:05:34Z","timestamp":1795025134828,"version":"4.10.2"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["#2022YFC2503300"],"award-info":[{"award-number":["#2022YFC2503300"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["#2022YFE0107600"],"award-info":[{"award-number":["#2022YFE0107600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#82220108015"],"award-info":[{"award-number":["#82220108015"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["#32470636"],"award-info":[{"award-number":["#32470636"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Taishan Scholar Programme of Shandong Province","award":["#tsqn202211377"],"award-info":[{"award-number":["#tsqn202211377"]}]},{"DOI":"10.13039\/501100007129","name":"Shandong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["#ZR2024MH031"],"award-info":[{"award-number":["#ZR2024MH031"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>Stage \u22653 chronic kidney disease (CKD) affects \u223c25% of people with gout. The effects of urate-lowering therapy (ULT) on CKD incidence and progression have remained inconclusive. Here, we assessed the impact of a gout ULT clinic intervention using artificial intelligence (AI) on CKD incidence and achievement of serum urate (SU) target.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An observational study compared propensity score (PS)-matched gout cohorts from an AI-based Gout Intelligent Management System (GIMS) and a standard Electronic Medical Records system (EMRS) clinic database. The GIMS included a mobile application, data fusion interface and modules for expert consultation and laboratory results management. All patients had gout and a starting estimated glomerular filtration rate &amp;gt;60\u2009ml\/min. Using a 1:2 PS-matched cohort study design, we assessed the impact of the AI-based system on CKD outcomes and ULT effectiveness over 4\u2009years of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Compared with EMRS, GIMS was associated with reduced incidence of CKD stage \u22653. Specifically, 169\/4117 new-onset CKD stage \u22653 (incidence 4.1 per 100 person-years) with GIMS compared with 164\/2128 with EMRS (incidence 7.7 per 100 person-years) during follow-up. More participants achieved SU &amp;lt;6.0\u2009mg\/dl with GIMS versus EMRS during follow-up (49.8% vs 25.9%, P &amp;lt; 0.001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Application of the artificial intelligence-based Gout Intelligent Management System was associated with lower incidence of chronic kidney disease stage \u22653 and superior target serum urate achievement in people with gout. The Gout Intelligent Management System\u00a0represents a novel approach to improve real-world renal outcomes and urate-lowering therapy success in gout.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keae616","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T19:50:58Z","timestamp":1730922658000},"page":"3048-3056","source":"Crossref","is-referenced-by-count":5,"title":["An artificial intelligence-based gout management system reduced chronic kidney disease incident and improved target serum urate achievement"],"prefix":"10.1093","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0720-2305","authenticated-orcid":false,"given":"Han","family":"Qi","sequence":"first","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2886-8285","authenticated-orcid":false,"given":"Jie","family":"Lu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Auckland , Auckland,","place":["New Zealand"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingshu","family":"Sun","sequence":"additional","affiliation":[{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Rheumatology, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Ji","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aichang","family":"Ji","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0719-3952","authenticated-orcid":false,"given":"Can","family":"Wang","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Sun","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinde","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"He","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Cui","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Han","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Quanzhou First Hospital Affiliated to Fujian Medical University , Quanzhou","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[{"name":"VA San Diego VA Healthcare Center, University of California San Diego , San Diego, CA","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4622-3731","authenticated-orcid":false,"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Shandong Provincial Clinical Research Center for Immune Diseases and Gout , Qingdao,","place":["China"]},{"name":"Shandong Provincial Key Laboratory of Metabolic Diseases and Qingdao Key Laboratory of Gout, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]},{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University , Qingdao,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,6]]},"reference":[{"key":"2025050316122468100_keae616-B1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"2025050316122468100_keae616-B2","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-015-0610-9","article-title":"Gout and risk of chronic kidney disease and nephrolithiasis: meta-analysis of observational studies","volume":"17","author":"Roughley","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2025050316122468100_keae616-B3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ekir.2022.11.016","article-title":"Uric acid and chronic kidney disease: still more to do","volume":"8","author":"Johnson","year":"2023","journal-title":"Kidney Int Rep"},{"key":"2025050316122468100_keae616-B4","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/rheumatology\/ker286","article-title":"Risk factors for acute kidney injury by non-steroidal anti-inflammatory drugs in patients with hyperuricaemia","volume":"50","author":"Moon","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"2025050316122468100_keae616-B5","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jamainternmed.2018.4463","article-title":"Association of chronic kidney disease with allopurinol use in gout treatment","volume":"178","author":"Vargas-Santos","year":"2018","journal-title":"JAMA Intern Med"},{"key":"2025050316122468100_keae616-B6","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMoa1915833","article-title":"Effects of allopurinol on the progression of chronic kidney disease","volume":"382","author":"Badve","year":"2020","journal-title":"N Engl J Med"},{"key":"2025050316122468100_keae616-B7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1053\/j.ajkd.2015.05.017","article-title":"Efficacy of febuxostat for slowing the GFR decline in patients with CKD and asymptomatic hyperuricemia: a 6-month, double-blind, randomized, placebo-controlled trial","volume":"66","author":"Sircar","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025050316122468100_keae616-B8","doi-asserted-by":"crossref","first-page":"e0187550","DOI":"10.1371\/journal.pone.0187550","article-title":"Effects of uric acid-lowering therapy in patients with chronic kidney disease: a meta-analysis","volume":"12","author":"Su","year":"2017","journal-title":"PLoS One"},{"key":"2025050316122468100_keae616-B9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13075-018-1746-1","article-title":"Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study","volume":"20","author":"Roughley","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2025050316122468100_keae616-B10","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10787-020-00694-7","article-title":"Better outcomes for patients with gout","volume":"28","author":"Day","year":"2020","journal-title":"Inflammopharmacology"},{"key":"2025050316122468100_keae616-B11","doi-asserted-by":"crossref","first-page":"e8532","DOI":"10.1097\/MD.0000000000008532","article-title":"Adherence to gout management recommendations of Chinese patients","volume":"96","author":"Sheng","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"2025050316122468100_keae616-B12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/ijpp\/riac025","article-title":"Clinical interventions to improve adherence to urate-lowering therapy in patients with gout: a systematic review","volume":"30","author":"Sinnappah","year":"2022","journal-title":"Int J Pharm Pract"},{"key":"2025050316122468100_keae616-B13","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(18)32158-5","article-title":"Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial","volume":"392","author":"Doherty","year":"2018","journal-title":"Lancet"},{"key":"2025050316122468100_keae616-B14","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.japh.2022.11.011","article-title":"Achievement of serum uric acid target by rheumatology clinic pharmacists compared with primary care providers in patients with gout","volume":"63","author":"Romano","year":"2023","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2025050316122468100_keae616-B15","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s40265-023-01944-y","article-title":"Emerging urate-lowering drugs and pharmacologic treatment strategies for gout: a narrative review","volume":"83","author":"Terkeltaub","year":"2023","journal-title":"Drugs"},{"key":"2025050316122468100_keae616-B16","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJMra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar","year":"2019","journal-title":"N Engl J Med"},{"key":"2025050316122468100_keae616-B17","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41551-018-0305-z","article-title":"Artificial intelligence in healthcare","volume":"2","author":"Yu","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"2025050316122468100_keae616-B18","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1016\/j.metabol.2018.08.002","article-title":"Omics, big data and machine learning as tools to propel understanding of biological mechanisms and to discover novel diagnostics and therapeutics","volume":"87","author":"Perakakis","year":"2018","journal-title":"Metabolism"},{"key":"2025050316122468100_keae616-B19","doi-asserted-by":"crossref","first-page":"101213","DOI":"10.1016\/j.xcrm.2023.101213","article-title":"Artificial intelligence in diabetes management: advancements, opportunities, and challenges","volume":"4","author":"Guan","year":"2023","journal-title":"Cell Rep Med"},{"key":"2025050316122468100_keae616-B20","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1002\/art.42635","article-title":"Metabolomics and machine learning identify metabolic differences and potential biomarkers for frequent versus infrequent gout flares","volume":"75","author":"Wang","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2025050316122468100_keae616-B21","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 Gout Classification Criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025050316122468100_keae616-B22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/art.41247","article-title":"2020 American College of Rheumatology Guideline for the Management of Gout","volume":"72","author":"FitzGerald","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2025050316122468100_keae616-B23","first-page":"1","article-title":"Guideline for the diagnosis and management of hyperuricemia and gout in China (2019)","volume":"36","author":"Chinese Society of Endocrinology CMA","year":"2020","journal-title":"Chin J Endocrinol Metab"},{"key":"2025050316122468100_keae616-B24","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"2025050316122468100_keae616-B25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41569-020-00503-2","article-title":"Artificial intelligence-enhanced electrocardiography in cardiovascular disease management","volume":"18","author":"Siontis","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2025050316122468100_keae616-B26","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.cmet.2018.09.005","article-title":"Patient-driven diabetes care of the future in the technology era","volume":"29","author":"Ashrafzadeh","year":"2019","journal-title":"Cell Metab"},{"key":"2025050316122468100_keae616-B27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.ajkd.2014.11.016","article-title":"Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial","volume":"65","author":"Goicoechea","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"2025050316122468100_keae616-B28","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3899\/jrheum.131159","article-title":"Effect of urate-lowering therapies on renal disease progression in patients with hyperuricemia","volume":"41","author":"Levy","year":"2014","journal-title":"J Rheumatol"},{"key":"2025050316122468100_keae616-B29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/annrheumdis-2015-209046","article-title":"Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare claims study of allopurinol use and incident renal failure","volume":"76","author":"Singh","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2025050316122468100_keae616-B30","doi-asserted-by":"crossref","first-page":"e2215878","DOI":"10.1001\/jamanetworkopen.2022.15878","article-title":"Association of uric acid-lowering therapy with incident chronic kidney disease","volume":"5","author":"Hassan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"2025050316122468100_keae616-B31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12882-024-03491-4","article-title":"Effects of uric acid-lowering therapy (ULT) on renal outcomes in CKD patients with asymptomatic hyperuricemia: a systematic review and meta-analysis","volume":"25","author":"Luo","year":"2024","journal-title":"BMC Nephrol"},{"key":"2025050316122468100_keae616-B32","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/art.39654","article-title":"Impact of febuxostat on renal function in gout patients with moderate-to-severe renal impairment","volume":"68","author":"Saag","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025050316122468100_keae616-B33","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1056\/NEJMoa1916624","article-title":"Serum urate lowering with allopurinol and kidney function in type 1 diabetes","volume":"382","author":"Doria","year":"2020","journal-title":"N Engl J Med"},{"key":"2025050316122468100_keae616-B34","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1681\/ASN.0000000000000326","article-title":"Combination treatment with verinurad and allopurinol in CKD: a randomized placebo and active controlled trial","volume":"35","author":"Heerspink","year":"2024","journal-title":"J Am Soc Nephrol"},{"key":"2025050316122468100_keae616-B35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/RHU.0b013e318204aab4","article-title":"Renal function in gout: long-term treatment effects of febuxostat","volume":"17","author":"Whelton","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"2025050316122468100_keae616-B36","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.3390\/ijms24043807","article-title":"Inhibition of xanthine oxidase protects against diabetic kidney disease through the amelioration of oxidative stress via VEGF\/VEGFR axis and NOX-FoxO3a-eNOS signaling pathway","volume":"24","author":"Yang","year":"2023","journal-title":"Int J Mol Sci"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumatology\/advance-article-pdf\/doi\/10.1093\/rheumatology\/keae616\/61099478\/keae616.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3048\/61099478\/keae616.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumatology\/article-pdf\/64\/5\/3048\/61099478\/keae616.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T20:12:35Z","timestamp":1746303155000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/64\/5\/3048\/7879352"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,6]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,11,6]]},"published-print":{"date-parts":[[2025,5,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keae616","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2024,11,6]]}}}